The Tokyo Foundation for Policy Research

ADVANCED SEARCH

The Tokyo Foundation for Policy Research

EXPERTS

櫻井 桂子/Keiko Sakurai

RESEARCH FELLOW

Keiko Sakurai

Last updated : April 19, 2024

Assistant Professor, Department of Health Policy and Management, Keio University School of Medicine

Areas of Expertise
  • Public health
  • health policy
  • health economics
  • mental health
  • prevention and management of chronic diseases

Bio
Keiko Sakurai, a pharmacist and MPH, is an assistant professor in the Department of Health Policy and Management at Keio University School of Medicine. She became a specially appointed assistant professor at the National University Hospital Database Center, University of Tokyo Hospital in 2015, a specially appointed researcher at the National Institute of Neurology and Psychiatry and National Center for Global Health in 2018, and assumed the position of a specially appointed assistant professor of Health Policy and Management at Keio University School of Medicine in 2020. Since 2022, she has also been a research partner of Data for Social Transformation, a general incorporated association.

Research Program
Developing a well-being-informed education package

Select Publications

  • Igarashi A, Maruyama-Sakurai K, Kubota A, Akiyama H, Yajima T, Kohsaka S, Miyata H. Cost-Effectiveness Analysis of Initiating Type 2 Diabetes Therapy with a Sodium-Glucose Cotransporter 2 Inhibitor Versus Conventional Therapy in Japan. Diabetes Ther. 2022 Jul;13(7):1367-1381.

  • Uchibori M, Ghaznavi C, Murakami M, Eguchi A, Kunishima H, Kaneko S, Maruyama-Sakurai K, Miyata H, Nomura S. Preventive Behaviors and Information Sources during COVID-19 Pandemic: A Cross-Sectional Study in Japan. Int J Environ Res Public Health. 2022 Nov 4;19(21):14511.

  • Nomura S, Eguchi A, Yoneoka D, Murakami M, Ghaznavi C, Gilmour S, Kaneko S, Kawashima T, Kunishima H, Naito W, Sakamoto H, Maruyama-Sakurai K, Takahashi A, Takayama Y, Tanoue Y, Yamamoto Y, Yasutaka T, Miyata H. Characterising reasons for reversals of COVID-19 vaccination hesitancy among Japanese people: One-year follow-up survey. Lancet Reg Health West Pac. 2022 Oct;27:100541. 

  • Adachi M, Murakami M, Yoneoka D, Kawashima T, Hashizume M, Sakamoto H, Eguchi A, Ghaznavi C, Gilmour S, Kaneko S, Kunishima H, Maruyama-Sakurai K, Tanoue Y, Yamamoto Y, Miyata H, Nomura S. Factors associated with the risk perception of COVID-19 infection and severe illness: A cross-sectional study in Japan. SSM Popul Health. 2022 Jun;18:101105.

  • Yoneoka D, Eguchi A, Nomura S, Kawashima T, Tanoue Y, Murakami M, Sakamoto H, Maruyama-Sakurai K, Gilmour S, Shi S, Kunishima H, Kaneko S, Adachi M, Shimada K, Yamamoto Y, Miyata H. Identification of optimum combinations of media channels for approaching COVID-19 vaccine unsure and unwilling groups in Japan. Lancet Reg Health West Pac. 2022 Jan;18:100330.

  • Shinjo D, Tachimori H, Maruyama-Sakurai K, Fujimori K, Inoue N, Fushimi K. Consultation-liaison psychiatry in Japan: a nationwide retrospective observational study. BMC Psychiatry. 2021 May 5;21(1):235.

  • Nomura S, Eguchi A, Yoneoka D, Kawashima T, Tanoue Y, Murakami M, Sakamoto H, Maruyama-Sakurai K, Gilmour S, Shi S, Kunishima H, Kaneko S, Adachi M, Shimada K, Yamamoto Y, Miyata H. Reasons for being unsure or unwilling regarding intention to take COVID-19 vaccine among Japanese people: A large cross-sectional national survey. Lancet Reg Health West Pac. 2021 Sep;14:100223.

  • Nomura S, Sakamoto H, Sugai MK, Nakamura H, Maruyama-Sakurai K, Lee S, Ishizuka A, Shibuya K. Tracking Japan's development assistance for health, 2012-2016. Global Health. 2020 Apr 15;16(1):32.

  • Shinjo D, Tachimori H, Maruyama-Sakurai K, Ohnuma T, Fujimori K, Fushimi K. Risk factors for early unplanned readmission in patients with bipolar disorder: A retrospective observational study. Gen Hosp Psychiatry. 2019 May - Jun;58:51-58.

Contact This Expert

MEDIA INQUIRIES

INQUIRIES

Click on the link below to contact an expert or submit a question.

CONTACT FORM